Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up.

ABSTRACT:

Purpose

To determine the relative efficacy and complications of the Ahmed glaucoma valve (AGV) model FP7 (New World Medical, Ranchos Cucamonga, CA) and the Baerveldt glaucoma implant (BGI) model 101-350 (Abbott Medical Optics, Abbott Park, IL) in refractory glaucoma.

Design

Multicenter, randomized, controlled clinical trial.

Participants

Two hundred seventy-six patients, including 143 in the AGV group and 133 in the BGI group.

Methods

Patients 18 to 85 years of age with refractory glaucoma having intraocular pressure (IOP) of 18 mmHg or more in whom an aqueous shunt was planned were randomized to undergo implantation of either an AGV or a BGI.

Main outcome measures

The primary outcome was failure, defined as IOP >21 mmHg or not reduced by 20% from baseli

SUBMITTER: Budenz DL 

PROVIDER: S-EPMC3020266 | biostudies-literature | 2011 Mar

REPOSITORIES: biostudies-literature